NCE Development Brochure Download
Sinopep is a leading CDMO specializing in the development and GMP manufacturing of peptide, oligonucleotide, and small molecule NCEs. With the rapidly expanding landscape of peptide therapeutics, we have grown our peptide CDMO platform into one of our most advanced and comprehensive capabilities, leveraging cutting-edge solid-phase and liquid-phase synthesis to tackle even the most complex and challenging sequences.
Other Brochures & Flyers of Interest
Oral delivery of semaglutide is limited by low membrane permeability and gastrointestinal degradation, restricting unassisted bioavailability to well below one percent, a barrier Rybelsus® overcomes...
Sinopep specializes in the development and CGMP manufacturing of peptide, oligonucleotide, and small molecule APIs for further processing, R&D, or compounding by licensed facilities. Our generic API...
